This article is more than 5 years old. Information may no longer be current.

Voluntary recall of allopurinol tablets issued by Qualitest

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

A voluntary recall of allopurinol tablets has been initiated by the manufacturer, according to an enforcement report published by the FDA this week.

The ongoing class III recall includes 21,552 units of 300mg allopurinol tablets sold in 500-count bottles manufactured by Qualitest Pharmaceuticals in Huntsville, AL. The lot number of affected products is CP0761501 and the expiration date is December 2016. The units are reported to contain oversized and discolored tablets, indicative of failure to meet the tablet manufacturing specifications. The affected allopurinol tablets were distributed to pharmacies nationwide in the U.S. and Puerto Rico, according to the report.

Reference: www.fda.gov.